HomeNAUT • NASDAQ
add
Nautilus Biotechnology Inc
Previous close
$1.81
Day range
$1.78 - $1.89
Year range
$0.62 - $2.54
Market cap
237.55M USD
Avg Volume
365.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.47M | -18.99% |
Net income | -13.57M | 17.46% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -15.05M | 19.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 131.43M | -6.53% |
Total assets | 200.92M | -22.64% |
Total liabilities | 31.78M | -12.39% |
Total equity | 169.14M | — |
Shares outstanding | 126.31M | — |
Price to book | 1.35 | — |
Return on assets | -18.68% | — |
Return on capital | -19.08% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -13.57M | 17.46% |
Cash from operations | -11.03M | 15.85% |
Cash from investing | 452.00K | 106.02% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -10.58M | 48.32% |
Free cash flow | -6.16M | 24.16% |
About
Founded
2016
Headquarters
Website
Employees
124
